Bausch Health
BHC
#4088
Rank
HK$24.17 B
Marketcap
HK$64.60
Share price
-1.96%
Change (1 day)
29.80%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -HK$20.80

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -HK$17.81. In 2022 the company made an earnings per share (EPS) of -HK$4.87 an increase over its 2021 EPS that were of -HK$20.85.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$20.80326.96%
2022-HK$4.87-76.64%
2021-HK$20.8568.45%
2020-HK$12.38-68.91%
2019-HK$39.81-57.11%
2018-HK$92.83-272.22%
2017HK$53.90-199.29%
2016-HK$54.29798.7%
2015-HK$6.04-128.31%
2014HK$21.34-204.62%
2013-HK$20.40602.7%
2012-HK$2.90-171.15%
2011HK$4.08-143.96%
2010-HK$9.28-206.57%
2009HK$8.71-11.2%
2008HK$9.812.46%
2007HK$9.57-7.58%
2006HK$10.36-14.29%
2005HK$12.0854%
2004HK$7.84-500%
2003-HK$1.96-141.67%
2002HK$4.71-4.76%
2001HK$4.94-175%
2000-HK$6.59-268%
1999HK$3.9214.94%
1998HK$3.4120.83%
1997HK$2.8253.83%
1996HK$1.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-HK$0.71-96.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$7.45-58.15%๐Ÿ‡บ๐Ÿ‡ธ USA